Literature DB >> 20535756

Validation of The Health Improvement Network (THIN) primary care database for monitoring prescriptions for smoking cessation medications.

Tessa E Langley1, Lisa Szatkowski, Jack Gibson, Yue Huang, Ann McNeill, Tim Coleman, Sarah Lewis.   

Abstract

PURPOSE: Evaluation of tobacco policy requires high quality and timely data on smoking cessation behaviour in the general population and in relevant target groups. Electronic primary care databases have the potential to provide a valuable source of data due to their size and continuity, and the availability of demographic and socioeconomic data. We therefore sought to investigate whether The Health Improvement Network (THIN) prescribing data are complete and can therefore be used to monitor trends in the prescribing of smoking cessation medications.
METHODS: The THIN smoking cessation medication prescriptions data for England were compared with smoking cessation medication dispensing data from NHS Prescription Services for January 2004 to December 2005.
RESULTS: Throughout the period the rates of prescribing and dispensing were very similar, both for nicotine replacement therapy (NRT) and bupropion combined, and for each type of medication alone. For NRT, dispensing exceeded recorded GP prescribing by 5.5% during the study period. For bupropion, prescribing exceeded dispensing by 5%.
CONCLUSIONS: THIN prescribing and national dispensing data are highly comparable. THIN prescribing data could potentially be used to monitor longitudinal trends in prescribing for smoking cessation medications.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20535756     DOI: 10.1002/pds.1960

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  13 in total

1.  Patterns of prescription of antidepressants and antipsychotics across and within pregnancies in a population-based UK cohort.

Authors:  Andrea V Margulis; Elizabeth M Kang; Tarek A Hammad
Journal:  Matern Child Health J       Date:  2014-09

2.  Digoxin use is associated with pancreatic cancer risk but does not affect survival.

Authors:  Ben Boursi; Jared S Huber; Kevin Haynes; Ronac Mamtani; Yu-Xiao Yang
Journal:  Cancer Causes Control       Date:  2020-10-16       Impact factor: 2.506

3.  Provision of smoking cessation support in UK primary care: impact of the 2012 QOF revision.

Authors:  Lisa Szatkowski; Paul Aveyard
Journal:  Br J Gen Pract       Date:  2015-12-06       Impact factor: 5.386

4.  Development of an algorithm for determining smoking status and behaviour over the life course from UK electronic primary care records.

Authors:  Mark D Atkinson; Jonathan I Kennedy; Ann John; Keir E Lewis; Ronan A Lyons; Sinead T Brophy
Journal:  BMC Med Inform Decis Mak       Date:  2017-01-05       Impact factor: 2.796

5.  Mortality gap for people with bipolar disorder and schizophrenia: UK-based cohort study 2000-2014.

Authors:  Joseph F Hayes; Louise Marston; Kate Walters; Michael B King; David P J Osborn
Journal:  Br J Psychiatry       Date:  2017-07-06       Impact factor: 9.319

6.  Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders.

Authors:  Gemma M J Taylor; Taha Itani; Kyla H Thomas; Dheeraj Rai; Tim Jones; Frank Windmeijer; Richard M Martin; Marcus R Munafò; Neil M Davies; Amy E Taylor
Journal:  Nicotine Tob Res       Date:  2020-01-27       Impact factor: 4.244

7.  Socioeconomic variations in access to smoking cessation interventions in UK primary care: insights using the Mosaic classification in a large dataset of primary care records.

Authors:  Laura Douglas; Lisa Szatkowski
Journal:  BMC Public Health       Date:  2013-06-05       Impact factor: 3.295

8.  General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.

Authors:  Michelle Johnson; Pippa Anderson; Ian Lockhart
Journal:  BMC Fam Pract       Date:  2014-03-20       Impact factor: 2.497

9.  What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study.

Authors:  Neil M Davies; Gemma Taylor; Amy E Taylor; Kyla H Thomas; Frank Windmeijer; Richard M Martin; Marcus R Munafò
Journal:  BMJ Open       Date:  2015-11-05       Impact factor: 2.692

10.  Stillbirth Among Women Prescribed Nicotine Replacement Therapy in Pregnancy: Analysis of a Large UK Pregnancy Cohort.

Authors:  Nafeesa N Dhalwani; Lisa Szatkowski; Tim Coleman; Linda Fiaschi; Laila J Tata
Journal:  Nicotine Tob Res       Date:  2019-03-30       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.